Roy de Souza (born 1970) is an engineer and writer. He is the co-founder of technology company ZEDO and medical technology company BreakBio.[1][2] In 2022, he was a TEDx speaker.[3] In May of 2023 he and his late wife were honored by the American Cancer Society for Roy's work in personalized medicine.[4]
De Souza served as a strategy consultant at the COBA Group, a strategy consulting boutique based in the UK.[5][6] He also worked in product management for the Elon Musk-founded web software company Zip2.[7]
De Souza founded technology company ZEDO in 1999.[1][8] In 2006, he founded the company Zebo, an offshoot of ZEDO focused on allowing users to catalog personal possessions and shop for similar items.[9][10][11] De Souza launched online ad exchange ZINC India in 2011, which was originally ZEDO's ad exchange platform in India before becoming a separate company.[12][13][14] He served as the ZEDO's CEO and oversaw the company as it transitioned into a subsidiary of Discovery following its acquisition by Discovery, Inc. in 2021.[15][16][17]
In 2022, he was a TEDx speaker, talking about vaccines to prevent cancer. .[3]
Cancer research
After his wife, Aisha de Sequeira's cancer diagnosis, de Souza became involved in vaccine research to develop a personalized vaccine for her cancer.[1] De Souza went on to co-found medical technology company BreakBio, basing the company in Boston, Massachusetts.[1][2][18] BreakBio develops personalized vaccines[2] and AI software that aids cancer treatments by identifying that difference between normal cells and cancer cells.[19] De Souza and Devabhaktuni Srikrishna also co-authored the book Cancer: What a Personal Crisis Taught Us About How T-Cells Can Save Your Life.[20]
Bibliography
De Souza, R. & Srikrishna, D. (2019). Cancer: What a personal crisis taught us about how T-cells can save your life. BreakBio Corp. ISBN978-0578548777
